Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

C21 Investments (CWLXF) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for C21 Investments (CWLXF) over the last 9 years, with Q4 2025 value amounting to $2.4 million.

  • C21 Investments' Cash & Equivalents fell 2582.39% to $2.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 million, marking a year-over-year decrease of 2582.39%. This contributed to the annual value of $2.6 million for FY2025, which is 1947.84% down from last year.
  • Latest data reveals that C21 Investments reported Cash & Equivalents of $2.4 million as of Q4 2025, which was down 2582.39% from $2.8 million recorded in Q3 2025.
  • C21 Investments' Cash & Equivalents' 5-year high stood at $6.2 million during Q1 2021, with a 5-year trough of $1.8 million in Q2 2023.
  • Over the past 5 years, C21 Investments' median Cash & Equivalents value was $2.8 million (recorded in 2025), while the average stood at $3.1 million.
  • Per our database at Business Quant, C21 Investments' Cash & Equivalents skyrocketed by 37444.32% in 2021 and then crashed by 5988.96% in 2022.
  • Quarter analysis of 5 years shows C21 Investments' Cash & Equivalents stood at $3.3 million in 2021, then changed by 0.0% to $3.3 million in 2022, then plummeted by 41.9% to $1.9 million in 2023, then surged by 71.15% to $3.3 million in 2024, then fell by 25.82% to $2.4 million in 2025.
  • Its Cash & Equivalents was $2.4 million in Q4 2025, compared to $2.8 million in Q3 2025 and $2.7 million in Q2 2025.